Apellis Pharmaceuticals Inc (APLS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | APLS | AMGN | VRTX | BMY | GILD |
| Company | Apellis Pharmaceuticals Inc | Amgen Inc | Vertex Pharmaceutic | Bristol-Myers Squibb Company | Gilead Sciences Inc |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NYSE | NASDAQ |
| Open | 33.05 | 262.21 | 407.20 | 57.66 | 93.17 |
| High | 33.23 | 264.73 | 410.82 | 57.88 | 94.25 |
| Low | 32.33 | 261.76 | 406.02 | 57.51 | 92.98 |
| Last | 32.96 | 263.64 | 409.54 | 57.67 | 94.12 |
| Change | -0.36 | -0.85 | +1.36 | -0.09 | +0.17 |
| % Change | -1.08% | -0.32% | +0.33% | -0.16% | +0.18% |
| Volume | 491,127 | 870,302 | 743,462 | 2,240,233 | 1,459,115 |
| 20-Day Average Volume | 2,617,592 | 4,190,896 | 1,801,579 | 11,126,940 | 7,024,181 |
| Previous Close | 33.32 | 264.49 | 408.18 | 57.76 | 93.95 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 33.84 | 271.17 | 449.13 | 57.81 | 92.43 |
| 20-Day Raw Stochastic | 27.27% | 32.28% | 32.22% | 52.32% | 87.27% |
| 20-Day Relative Strength | 52.56% | 32.67% | 34.62% | 53.68% | 58.19% |
| Weighted Alpha | -42.79 | -15.22 | -7.44 | +20.28 | +26.09 |
| Today's Opinion | 24% Sell | 88% Sell | 72% Sell | 80% Buy | 100% Buy |
| Previous Opinion | 24% Sell | 88% Sell | 72% Sell | 80% Buy | 100% Buy |
| Last Month's Opinion | 56% Sell | 72% Sell | 8% Sell | 100% Buy | 80% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -3.47% since 12/18/24 | +1.67% since 12/18/24 | -8.46% since 12/18/24 | +1.48% since 12/18/24 | +3.59% since 12/18/24 |
| Low | 32.33 on 12/26/24 | 253.30 on 12/19/24 | 377.85 on 12/19/24 | 56.08 on 12/20/24 | 90.27 on 12/19/24 |
| High | 34.27 on 12/20/24 | 269.61 on 12/20/24 | 410.82 on 12/26/24 | 57.88 on 12/26/24 | 94.25 on 12/26/24 |
| 1-Month | |||||
| %Chg | +0.64% since 11/26/24 | -6.04% since 11/26/24 | -12.30% since 11/26/24 | -1.80% since 11/26/24 | +2.85% since 11/26/24 |
| Low | 31.76 on 12/13/24 | 253.30 on 12/19/24 | 377.85 on 12/19/24 | 55.04 on 12/13/24 | 89.15 on 12/13/24 |
| High | 35.72 on 12/09/24 | 283.64 on 11/29/24 | 476.46 on 12/10/24 | 60.09 on 12/03/24 | 94.65 on 12/11/24 |
| 3-Month | |||||
| %Chg | +10.02% since 09/26/24 | -17.55% since 09/26/24 | -11.56% since 09/26/24 | +15.09% since 09/26/24 | +13.14% since 09/26/24 |
| Low | 24.34 on 11/05/24 | 253.30 on 12/19/24 | 377.85 on 12/19/24 | 50.71 on 09/27/24 | 82.82 on 10/01/24 |
| High | 35.72 on 12/09/24 | 329.17 on 10/11/24 | 519.88 on 11/08/24 | 61.08 on 11/11/24 | 98.90 on 11/11/24 |
| 6-Month | |||||
| %Chg | -18.77% since 06/26/24 | -15.90% since 06/26/24 | -13.58% since 06/26/24 | +35.72% since 06/26/24 | +35.55% since 06/26/24 |
| Low | 24.34 on 11/05/24 | 253.30 on 12/19/24 | 377.85 on 12/19/24 | 39.35 on 07/05/24 | 66.01 on 07/05/24 |
| High | 42.47 on 07/16/24 | 346.85 on 07/25/24 | 519.88 on 11/08/24 | 61.08 on 11/11/24 | 98.90 on 11/11/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 4,144,775 | 142,172,096 | 105,118,176 | 117,147,504 | 117,086,688 |
| Shares Outstanding, K | 124,393 | 537,533 | 257,529 | 2,028,177 | 1,246,266 |
| Annual Sales | 396,590,000 | 28,190,000,000 | 9,869,200,000 | 45,006,000,000 | 27,116,000,000 |
| Annual Net Income | -528,630,000 | 6,717,000,000 | 3,619,600,000 | 8,025,000,000 | 5,665,000,000 |
| Last Quarter Sales | 196,830,000 | 8,503,000,000 | 2,771,900,000 | 11,892,000,000 | 7,545,000,000 |
| Last Quarter Net Income | -57,450,000 | 2,830,000,000 | 1,045,400,000 | 1,211,000,000 | 1,253,000,000 |
| 60-Month Beta | 0.94 | 0.55 | 0.36 | 0.45 | 0.18 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.46 on 11/05/24 | 5.58 on 10/30/24 | 4.38 on 11/04/24 | 1.80 on 10/31/24 | 2.02 on 11/06/24 |
| Latest Earnings Date | 11/05/24 | 02/04/25 | 02/03/25 | 02/06/25 | 02/11/25 |
| Most Recent Dividend | N/A | 2.250 on 11/18/24 | N/A | 0.600 on 10/04/24 | 0.770 on 12/13/24 |
| Next Ex-Dividends Date | N/A | 02/14/25 | N/A | 01/03/25 | 12/13/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 13.74 | 0.00 | 49.21 | 21.08 |